As part of its ongoing commitment to supporting research in women’s health, the Massachusetts Life Sciences Center (MLSC) is proud to highlight the Dana-Farber Cancer Institute and Dr. Elizabeth A. Mittendorf’s project on leveraging digital pathology to identify and cure high risk breast cancer.
Partnering with PathAI, Dr. Mittendorf was awarded more than $740,000 through the MLSC’s Women’s Health Collaboration program in 2021. Her project involved designing computer algorithms capable of identifying features in tumor biopsies and surgical specimens that can distinguish between high- and low-risk breast tumors.
The Women’s Health Collaboration program is part of the MLSC’s Women’s Health Initiative. The program supports collaborative projects that aim to improve the discovery, technical innovation, and/or analysis of datasets to answer pressing life science questions around women’s health. It incentivizes translational projects that develop novel solutions to treat conditions that solely or disproportionately affect women or have a different presentation between genders.
The MLSC Women’s Health Initiative is accepting applications through Dec. 6, 2024 at 1 p.m. EST. Click here to learn more.
